Obesity and CardiovascularDiseases

Brinton D, Napheys G: Personal beauty: how to cultivate and preserve it in accordance with the laws of health, 1870. Available at: https://books.google.com/books?hl=en&lr=&id=PDUEAAAAYAAJ&oi=fnd&pg=PA9&dq=Personal+beauty:+how+to+cultivate+and+preserve+it+in+accordance+with+the+laws+of+health&ots=XiKZATnvBz&sig=_pt4TkIuIOXBJmtEoEjsjBRcobU. Cited February 6, 2017. Ortega, 2016, Obesity and cardiovascular disease, Circ Res, 118, 1752, 10.1161/CIRCRESAHA.115.306883 Maclennan W. On the treatment of obesity and myxoedema by a new preparation of thyroid “Thyroglandin”. Br Med J, BMJ Group, 1898. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20757948. Cited February 6, 2017;2(1958):79-80. Oliver T. Post-mortem in a case of extreme obesity. J Anat Physiol. Wiley-Blackwell; 1880;14(Pt 3):345-347. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17231332. Cited February 6, 2017. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 2014;384(9945):766-781. Available at: http://linkinghub.elsevier.com/retrieve/pii/S0140673614604608. Cited February 6, 2017. Alpert MA, Lavie CJ, Agrawal H, et al. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management, Transl Res, 2014; Available at: http://www.sciencedirect.com/science/article/pii/S1931524414001340. Cited Dec 27, 2015;164(4):345-356. Lavie, 2013, Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure, JACC Heart Fail, 1, 93, 10.1016/j.jchf.2013.01.006 Lavie, 2016, Obesity and prevalence of cardiovascular diseases and prognosis—the obesity paradox updated, Prog Cardiovasc Dis, 58, 537, 10.1016/j.pcad.2016.01.008 Aune, 2016, Body mass index, abdominal fatness and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies, Circulation, 115 Lavie, 2009, Obesity and cardiovascular disease. Risk factor, paradox, and impact of weight loss, 53, 1925 Parto P, Lavie CJ, Ventura HO. Reducing heart failure risks in obese patients. Curr Cardiovasc Risk Rep. Springer, US; Available at: http://link.springer.com/10.1007/s12170-016-0498-1. 2016; cited February 9, 2017;10:15. Lavie, 2014, Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox, J Am Coll Cardiol, 63, 1345, 10.1016/j.jacc.2014.01.022 Lavie, 2015, Body composition and the obesity paradox in coronary heart disease: can heavier really be healthier?, Heart, 101, 1610, 10.1136/heartjnl-2015-307966 Nakamura, 2014, Adipokines: a link between obesity and cardiovascular disease, J Cardiol, 63, 250, 10.1016/j.jjcc.2013.11.006 Hirsch, 1976, Adipose tissue cellularity in human obesity, Clin Endocrinol Metab, 5, 299, 10.1016/S0300-595X(76)80023-0 Hausman DB, DiGirolamo M, Bartness TJ, et al. The biology of white adipocyte proliferation. Obes Rev. Blackwell Science Ltd; Available at: http://doi.wiley.com/10.1046/j.1467-789X.2001.00042.x. Cited February 12, 2017;2:239-254. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. American Society for Biochemistry and Molecular Biology; Available at: http://www.ncbi.nlm.nih.gov/pubmed/16150820. Cited February 12, 2017;46:2347-2355. Strissel, 2007, Adipocyte death, adipose tissue remodeling, and obesity complications, Diabetes, 56, 1, 10.2337/db07-0767 Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, 112, 1821 Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, 112, 1796 Gordon, 2003, Alternative activation of macrophages, 3, 23 Odegaard, 2011, Alternative macrophage activation and metabolism, 6, 275 Feingold, 2010, The acute phase response inhibits reverse cholesterol transport, 51, 682 Feingold, 2000, Obesity and dyslipidemia Lara-Castro, 2007, Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease, Curr Opin Lipidol, 18, 263, 10.1097/MOL.0b013e32814a645f Winer, 2009, Normalization of obesity-associated insulin resistance through immunotherapy, 15, 921 Winer, 2011, B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies, 17, 610 Liu, 2009, Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice, 15, 940 Talukdar, 2012, Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase, 18, 1407 Wu, 2011, Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis, Science, 332, 243, 10.1126/science.1201475 Nakajima, 1985, Noninvasive study of left ventricular performance in obese patients: Influence of duration of obesity, Circulation, 71, 481, 10.1161/01.CIR.71.3.481 Alpert, 1995, Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss, Am J Cardiol, 76, 1194, 10.1016/S0002-9149(99)80338-5 Patel, 2012, Association of left ventricular geometry with left atrial enlargement in patients with preserved ejection fraction, Congest Heart Fail, 18, 4, 10.1111/j.1751-7133.2011.00264.x Baptista de Faria, 2016, Abstract 20159: longitudinal impact of childhood bmi on cardiac structure and function, Circulation, 134 Lauer, 1991, The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study, J Am Med Assoc, 266, 231, 10.1001/jama.1991.03470020057032 Alpert, 1998, Cardiac morphology and obesity in man, 25 Alexander, 1998, Hemodynamic alterations with obesity in man. In:, 45 Wong, 2004, Alterations of left ventricular myocardial characteristics associated with obesity, Circulation, 110, 3081, 10.1161/01.CIR.0000147184.13872.0F Gelber, 2007, A prospective study of body mass index and the risk of developing hypertension in men, Am J Hypertens, 20, 370, 10.1016/j.amjhyper.2006.10.011 Hsueh, 1994, Obesity and hypertension, Endocrinol Metab Clin North Am, 23, 405, 10.1016/S0889-8529(18)30105-1 Alpert, 2001, Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome, Am J Med Sci, 321, 225, 10.1097/00000441-200104000-00003 Messerli, 1983, Disparate cardiovascular effects of obesity and arterial hypertension, Am J Med, 74, 808, 10.1016/0002-9343(83)91071-9 Messerli, 1983, Dimorphic cardiac adaptation to obesity and arterial hypertension, 99, 757 Aurigemma, 2013, Cardiac remodeling in obesity, Circ Cardiovasc Imaging, 6, 142, 10.1161/CIRCIMAGING.111.964627 Neeland, 2013, Relation of regional fat distribution to left ventricular structure and function, Circ Cardiovasc Imaging, 6, 800, 10.1161/CIRCIMAGING.113.000532 Moore, 2005, Weight loss in overweight adults and the long-term risk of hypertension, 165, 1298 Parto, 2015, The role of cardiorespiratory fitness on plasma lipid levels, Expert Rev Cardiovasc Ther, 13, 1177, 10.1586/14779072.2015.1092384 Park, 2015, The effect of cardiorespiratory fitness on age-related lipids and lipoproteins, J Am Coll Cardiol, 65, 2091, 10.1016/j.jacc.2015.03.517 Cullen, 2000, Evidence that triglycerides are an independent coronary heart disease risk factor, Am J Cardiol, 86, 943, 10.1016/S0002-9149(00)01127-9 Cui, 2001, Non–high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality, 161, 1413 Anderson, 1987, Cholesterol and mortality, 257, 2176 Church, 2015, Exercise and Lipids Halverstadt, 2007, Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women, Metabolism, 56, 444, 10.1016/j.metabol.2006.10.019 Grundy, 2004, Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E 2001, Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), J Am Med Assoc, 285, 2486, 10.1001/jama.285.19.2486 Eckel, 2014, 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk, J Am Coll Cardiol, 63(25 Part B), 2960, 10.1016/j.jacc.2013.11.003 Shaw, 2006, Exercise for overweight or obesity Grundy, 2004, Definition of metabolic syndrome, Circulation, 109, 433, 10.1161/01.CIR.0000111245.75752.C6 Williams, 2002, Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report, Circulation, 106, 3143, 10.1161/circ.106.25.3143 Kaur, 2014, A comprehensive review on metabolic syndrome, Cardiol Res Pract, 2014, 10.1155/2014/943162 Katzmarzyk, 2005, Metabolic syndrome, obesity, and mortality, Diab Care, 28, 391, 10.2337/diacare.28.2.391 Isomaa, 2001, Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diab Care, 24, 683, 10.2337/diacare.24.4.683 Calori, 2010, Prevalence, metabolic features, and prognosis of metabolically healthy obese italian individuals, Diab Care, 34 Fan, 2013, Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies, Int J Cardiol, 168, 4761, 10.1016/j.ijcard.2013.07.230 Ortega, 2015, Role of fitness in the metabolically healthy but obese phenotype: a review and update, Prog Cardiovasc Dis, 58, 76, 10.1016/j.pcad.2015.05.001 Lavie, 2014, Healthy obese versus unhealthy lean: the obesity paradox, 11, 55 Hatem, 2015, Atrial fibrillation and obesity, J Am Coll Cardiol, 66, 12, 10.1016/j.jacc.2015.04.057 Abed, 2013, Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation, Heart Rhythm, 10, 90, 10.1016/j.hrthm.2012.08.043 Wanahita, 2008, Atrial fibrillation and obesity—results of a meta-analysis, Am Heart J, 155, 310, 10.1016/j.ahj.2007.10.004 Wang, 2004, Obesity and the risk of new-onset atrial fibrillation, 292, 2471 Rabah, 2014, Atrial fibrillation in heart failure: catheter and surgical interventional therapies, Heart Fail Rev, 19, 325, 10.1007/s10741-013-9411-x Shinbane, 1997, Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies, 29, 709 Clark, 1997, Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation, 30, 1039 Wang, 2003, Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study, Circulation, 107, 2920, 10.1161/01.CIR.0000072767.89944.6E Benjamin, 1994, Independent risk factors for atrial fibrillation in a population-based cohort, 271, 840 Luppino, 2010, Overweight, obesity, and depression, 67, 220 Elderon, 2013, Depression and cardiovascular disease, Prog Cardiovasc Dis, 55, 511, 10.1016/j.pcad.2013.03.010 Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9 Charlson, 2011, Should global burden of disease estimates include depression as a risk factor for coronary heart disease?, 9, 47 Lavie, 2016, Impact of cardiac rehabilitation and exercise training on psychological risk factors and subsequent prognosis in patients with cardiovascular disease, Can J Cardiol, 32, S365, 10.1016/j.cjca.2016.07.508 Ernstsen, 2016, Protective effect of regular physical activity on depression after myocardial infarction: the Hunt Study, Am J Med, 129, 82, 10.1016/j.amjmed.2015.08.012 Kachur, 2016, Significance of comorbid psychological stress and depression on outcomes after cardiac rehabilitation, Am J Med, 129, 1316, 10.1016/j.amjmed.2016.07.006 Stunkard, 2003, Depression and obesity, Biol Psychiatry, 54, 330, 10.1016/S0006-3223(03)00608-5 Bornstein, 2006, Approaching the shared biology of obesity and depression: the stress axis as the locus of gene–environment interactions, Mol Psychiatry, 11, 892, 10.1038/sj.mp.4001873 Blaine B. Does depression cause obesity? J Health Psychol SAGE Publications, UK; 2008;13:1190–1197. http://dx.doi.org/10.1177/1359105308095977. [cited February 25, 2017]. Lavie, 2015, Update on obesity and obesity paradox in heart failure, Prog Cardiovasc Dis Lavie, 2003, Body composition and prognosis in chronic systolic heart failure: the obesity paradox, Am J Cardiol, 91, 891, 10.1016/S0002-9149(03)00031-6 Sharma, 2015, Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure, Am J Cardiol, 115, 1428, 10.1016/j.amjcard.2015.02.024 Wang, 2015, Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis, Heart, 101, 1631, 10.1136/heartjnl-2014-307119 Flegal, 2013, Association of all-cause mortality with overweight and obesity using standard body mass index categories, 309, 71 Coutinho, 2013, Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of normal weight central obesity, J Am Coll Cardiol, 61, 553, 10.1016/j.jacc.2012.10.035 Coutinho, 2011, Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data, J Am Coll Cardiol, 57, 1877, 10.1016/j.jacc.2010.11.058 Wessel, 2004, Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women, 292, 1179 Artero, 2011, A prospective study of muscular strength and all-cause mortality in men with hypertension, 57, 1831 Blair, 1996, Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women, 276, 205 Lavie, 2013, Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure, Mayo Clin Proc, 88, 251, 10.1016/j.mayocp.2012.11.020 McAuley, 2012, The obesity paradox, cardiorespiratory fitness, and coronary heart disease, Mayo Clin Proc, 87, 443, 10.1016/j.mayocp.2012.01.013 Uretsky, 2013, The interaction of exercise ability and body mass index upon long-term outcomes among patients undergoing stress-rest perfusion single-photon emission computed tomography imaging, Am Heart J, 166, 127, 10.1016/j.ahj.2013.03.027 De Schutter, 2014, The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease-the obesity paradox, Prog Cardiovasc Dis, 56, 401, 10.1016/j.pcad.2013.08.003 Archer, 2016, The Validity of US Nutritional Surveillance: USDA's Loss-Adjusted Food Availability Data Series 1971-2010, Curr Probl Cardiol., 41, 268, 10.1016/j.cpcardiol.2016.10.007